Evidence map›Paper›PMID 39639481›Full record

ArticleEpidemiology and infection2024

Measles and rubella seroprevalence in adults using residual blood samples from health facilities and household serosurveys in Palghar District, Maharashtra, India, 2018 - 2019.

Christine Prosperi, Alvira Z Hasan, Amy K Winter, Itta Krishna Chaaithanya, Neha R Salvi, Sanjay L Chauhan, Ragini N Kulkarni, Abhishek Lachyan, Poonam Gawali, Mitali Kapoor and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Christine ProsperiInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0003-1942-5319
Alvira Z HasanInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Amy K WinterInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0003-2737-7003
Itta Krishna ChaaithanyaDepartment of Health Research, Model Rural Health Research Unit, Dahanu, India.
Neha R SalviDepartment of Health Research, Model Rural Health Research Unit, Dahanu, India.
Sanjay L ChauhanIndian Council of Medical Research, National Institute for Research in Reproductive and Child Health (NIRRCH), Mumbai, India.
Ragini N KulkarniIndian Council of Medical Research, National Institute for Research in Reproductive and Child Health (NIRRCH), Mumbai, India.
Abhishek LachyanDepartment of Health Research, Model Rural Health Research Unit, Dahanu, India.
Poonam GawaliDepartment of Health Research, Model Rural Health Research Unit, Dahanu, India.
Mitali KapoorDepartment of Health Research, Model Rural Health Research Unit, Dahanu, India.
Vaishali BhattDiagnostic Virology Group, Indian Council of Medical Research, National Institute of Virology, Pune, India.
Ojas KaduskarDiagnostic Virology Group, Indian Council of Medical Research, National Institute of Virology, Pune, India.
Gururaj Rao DeshpandeDiagnostic Virology Group, Indian Council of Medical Research, National Institute of Virology, Pune, India.
Ignacio EstebanInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sabarinathan RamasamyIndian Council of Medical Research (ICMR), National Institute of Epidemiology, Chennai, India.
Velusamy Saravana KumarIndian Council of Medical Research (ICMR), National Institute of Epidemiology, Chennai, India.
Shaun A TrueloveInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Muthusamy Santhosh KumarIndian Council of Medical Research (ICMR), National Institute of Epidemiology, Chennai, India.
Jeromie W Vivian ThangarajIndian Council of Medical Research (ICMR), National Institute of Epidemiology, Chennai, India.
Lucky SangalWorld Health Organization, Southeast Asia Region Office, New Delhi, India.
Sanjay M MehendalePD Hinduja Hospital and Medical Research Centre, Mumbai, India.
Gajanan N SapkalDiagnostic Virology Group, Indian Council of Medical Research, National Institute of Virology, Pune, India.
Nivedita GuptaDivision of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Kyla HayfordInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0002-9872-2313
William J MossInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Manoj V MurhekarIndian Council of Medical Research (ICMR), National Institute of Epidemiology, Chennai, India.

Funding

Bill and Melinda Gates Foundation 1094816World Health Organization 001
6 · The paper itself

Abstract

Residual blood specimens collected at health facilities may be a source of samples for serosurveys of adults, a population often neglected in community-based serosurveys. Anonymized residual blood specimens were collected from individuals 15 - 49 years of age attending two sub-district hospitals in Palghar District, Maharashtra, from November 2018 to March 2019. Specimens also were collected from women 15 - 49 years of age enrolled in a cross-sectional, community-based serosurvey representative at the district level that was conducted 2 - 7 months after the residual specimen collection. Specimens were tested for IgG antibodies to measles and rubella viruses. Measles and rubella seroprevalence estimates using facility-based specimens were 99% and 92%, respectively, with men having significantly lower rubella seropositivity than women. Age-specific measles and rubella seroprevalence estimates were similar between the two specimen sources. Although measles seropositivity was slightly higher among adults attending the facilities, both facility and community measles seroprevalence estimates were 95% or higher. The similarity in measles and rubella seroprevalence estimates between the community-based and facility serosurveys highlights the potential value of residual specimens to approximate community seroprevalence.

Indexed as

Antibodies, ViralMeaslesRubellaAdolescentAdultCross-Sectional StudiesFamily CharacteristicsFemaleHealth FacilitiesHumansImmunoglobulin GIndiaMaleMeasles virusMiddle AgedRubella virusAntibodies, ViralImmunoglobulin Gmeasles (rubeola)rubellaserologyvaccines

Identifiers

PMID39639481
PMCPMC11626445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.